Limit Use of Voquezna for H. pylori

August 2022

Voquezna Dual Pak and Triple Pak will be new Rx combos for treating H. pylori.

These combos contain vonoprazan...the first potassium-competitive acid blocker (PCAB).

Think of vonoprazan as a “fancy PPI”...with some differences.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Statins Take a Stepwise Approach to Statin Intolerance
Asthma Update Action Plans When Using SMART for Moderate to Severe Asthma
Cardiology Know When to Consider QT Prolongation Alerts as “Critical”
Gastroenterology Limit Use of Voquezna for H. pylori
Immunizations Keep Adolescents on Track With Immunizations
Anticoagulants Ensure Appropriate DOAC Dosing
Oral Health Navigate Treatments for Canker and Cold Sores
Interactions Be Familiar With “New” Transporter Drug Interactions
Supplements Put Supplements for Osteoarthritis in Perspective
IV Medications Incorporate ICU Fluid Stewardship Into Your Practice
Opioids Compare Nalmefene to Naloxone for Opioid Overdose